1 Market Overview

1.1 Product Overview and Scope of CMO and CDMO biotechnology

1.2 Classification of CMO and CDMO biotechnology by Type

1.2.1 Overview: Global CMO and CDMO biotechnology Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global CMO and CDMO biotechnology Revenue Market Share by Type in 2020

1.2.3 Service

1.2.4 Product

1.2.5 Platform/ Expression System

1.3 Global CMO and CDMO biotechnology Market by Application

1.3.1 Overview: Global CMO and CDMO biotechnology Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Large Enterprise

1.3.3 SME

1.4 Global CMO and CDMO biotechnology Market Size & Forecast

1.5 Global CMO and CDMO biotechnology Market Size and Forecast by Region

1.5.1 Global CMO and CDMO biotechnology Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global CMO and CDMO biotechnology Market Size by Region, (2016-2021)

1.5.3 North America CMO and CDMO biotechnology Market Size and Prospect (2016-2026)

1.5.4 Europe CMO and CDMO biotechnology Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific CMO and CDMO biotechnology Market Size and Prospect (2016-2026)

1.5.6 South America CMO and CDMO biotechnology Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa CMO and CDMO biotechnology Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 CMO and CDMO biotechnology Market Drivers

1.6.2 CMO and CDMO biotechnology Market Restraints

1.6.3 CMO and CDMO biotechnology Trends Analysis

2 Company Profiles

2.1 Patheon

2.1.1 Patheon Details

2.1.2 Patheon Major Business

2.1.3 Patheon CMO and CDMO biotechnology Product and Solutions

2.1.4 Patheon CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Patheon Recent Developments and Future Plans

2.2 Catalent

2.2.1 Catalent Details

2.2.2 Catalent Major Business

2.2.3 Catalent CMO and CDMO biotechnology Product and Solutions

2.2.4 Catalent CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Catalent Recent Developments and Future Plans

2.3 Samsung Biologics

2.3.1 Samsung Biologics Details

2.3.2 Samsung Biologics Major Business

2.3.3 Samsung Biologics CMO and CDMO biotechnology Product and Solutions

2.3.4 Samsung Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Samsung Biologics Recent Developments and Future Plans

2.4 Lonza.

2.4.1 Lonza. Details

2.4.2 Lonza. Major Business

2.4.3 Lonza. CMO and CDMO biotechnology Product and Solutions

2.4.4 Lonza. CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Lonza. Recent Developments and Future Plans

2.5 Boehringer Ingelheim

2.5.1 Boehringer Ingelheim Details

2.5.2 Boehringer Ingelheim Major Business

2.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Product and Solutions

2.5.4 Boehringer Ingelheim CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Boehringer Ingelheim Recent Developments and Future Plans

2.6 Samsung BioLogics

2.6.1 Samsung BioLogics Details

2.6.2 Samsung BioLogics Major Business

2.6.3 Samsung BioLogics CMO and CDMO biotechnology Product and Solutions

2.6.4 Samsung BioLogics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Samsung BioLogics Recent Developments and Future Plans

2.7 AGC Biologics

2.7.1 AGC Biologics Details

2.7.2 AGC Biologics Major Business

2.7.3 AGC Biologics CMO and CDMO biotechnology Product and Solutions

2.7.4 AGC Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 AGC Biologics Recent Developments and Future Plans

2.8 WuXi Biologics

2.8.1 WuXi Biologics Details

2.8.2 WuXi Biologics Major Business

2.8.3 WuXi Biologics CMO and CDMO biotechnology Product and Solutions

2.8.4 WuXi Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 WuXi Biologics Recent Developments and Future Plans

2.9 AbbVie

2.9.1 AbbVie Details

2.9.2 AbbVie Major Business

2.9.3 AbbVie CMO and CDMO biotechnology Product and Solutions

2.9.4 AbbVie CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 AbbVie Recent Developments and Future Plans

2.10 Avid Bioservices

2.10.1 Avid Bioservices Details

2.10.2 Avid Bioservices Major Business

2.10.3 Avid Bioservices CMO and CDMO biotechnology Product and Solutions

2.10.4 Avid Bioservices CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Avid Bioservices Recent Developments and Future Plans

2.11 Fujifilm Diosynth Biotechnologies

2.11.1 Fujifilm Diosynth Biotechnologies Details

2.11.2 Fujifilm Diosynth Biotechnologies Major Business

2.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product and Solutions

2.11.4 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans

2.12 KBI Biopharma (JSR Corporation)

2.12.1 KBI Biopharma (JSR Corporation) Details

2.12.2 KBI Biopharma (JSR Corporation) Major Business

2.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product and Solutions

2.12.4 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 KBI Biopharma (JSR Corporation) Recent Developments and Future Plans

2.13 Cytovance Biologics

2.13.1 Cytovance Biologics Details

2.13.2 Cytovance Biologics Major Business

2.13.3 Cytovance Biologics CMO and CDMO biotechnology Product and Solutions

2.13.4 Cytovance Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Cytovance Biologics Recent Developments and Future Plans

2.14 Xpress Biologic

2.14.1 Xpress Biologic Details

2.14.2 Xpress Biologic Major Business

2.14.3 Xpress Biologic CMO and CDMO biotechnology Product and Solutions

2.14.4 Xpress Biologic CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Xpress Biologic Recent Developments and Future Plans

2.15 Rentschler Biopharma

2.15.1 Rentschler Biopharma Details

2.15.2 Rentschler Biopharma Major Business

2.15.3 Rentschler Biopharma CMO and CDMO biotechnology Product and Solutions

2.15.4 Rentschler Biopharma CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Rentschler Biopharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global CMO and CDMO biotechnology Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 CMO and CDMO biotechnology Players Market Share

3.2.2 Top 10 CMO and CDMO biotechnology Players Market Share

3.2.3 Market Competition Trend

3.3 CMO and CDMO biotechnology Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global CMO and CDMO biotechnology Revenue and Market Share by Type (2016-2021)

4.2 Global CMO and CDMO biotechnology Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global CMO and CDMO biotechnology Revenue Market Share by Application (2016-2021)

5.2 CMO and CDMO biotechnology Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America CMO and CDMO biotechnology Revenue by Type (2016-2026)

6.2 North America CMO and CDMO biotechnology Revenue by Application (2016-2026)

6.3 North America CMO and CDMO biotechnology Market Size by Country

6.3.1 North America CMO and CDMO biotechnology Revenue by Country (2016-2026)

6.3.2 United States CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

6.3.3 Canada CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

6.3.4 Mexico CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe CMO and CDMO biotechnology Revenue by Type (2016-2026)

7.2 Europe CMO and CDMO biotechnology Revenue by Application (2016-2026)

7.3 Europe CMO and CDMO biotechnology Market Size by Country

7.3.1 Europe CMO and CDMO biotechnology Revenue by Country (2016-2026)

7.3.2 Germany CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

7.3.3 France CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

7.3.4 United Kingdom CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

7.3.5 Russia CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

7.3.6 Italy CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific CMO and CDMO biotechnology Revenue by Type (2016-2026)

8.2 Asia-Pacific CMO and CDMO biotechnology Revenue by Application (2016-2026)

8.3 Asia-Pacific CMO and CDMO biotechnology Market Size by Region

8.3.1 Asia-Pacific CMO and CDMO biotechnology Revenue by Region (2016-2026)

8.3.2 China CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

8.3.3 Japan CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

8.3.4 South Korea CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

8.3.5 India CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

8.3.7 Australia CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America CMO and CDMO biotechnology Revenue by Type (2016-2026)

9.2 South America CMO and CDMO biotechnology Revenue by Application (2016-2026)

9.3 South America CMO and CDMO biotechnology Market Size by Country

9.3.1 South America CMO and CDMO biotechnology Revenue by Country (2016-2026)

9.3.2 Brazil CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

9.3.3 Argentina CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa CMO and CDMO biotechnology Revenue by Type (2016-2026)

10.2 Middle East & Africa CMO and CDMO biotechnology Revenue by Application (2016-2026)

10.3 Middle East & Africa CMO and CDMO biotechnology Market Size by Country

10.3.1 Middle East & Africa CMO and CDMO biotechnology Revenue by Country (2016-2026)

10.3.2 Turkey CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

10.3.4 UAE CMO and CDMO biotechnology Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global CMO and CDMO biotechnology Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global CMO and CDMO biotechnology Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market CMO and CDMO biotechnology Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global CMO and CDMO biotechnology Revenue (USD Million) by Region (2016-2021)

Table 5. Global CMO and CDMO biotechnology Revenue Market Share by Region (2021-2026)

Table 6. Patheon Corporate Information, Head Office, and Major Competitors

Table 7. Patheon Major Business

Table 8. Patheon CMO and CDMO biotechnology Product and Solutions

Table 9. Patheon CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Catalent Corporate Information, Head Office, and Major Competitors

Table 11. Catalent Major Business

Table 12. Catalent CMO and CDMO biotechnology Product and Solutions

Table 13. Catalent CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Samsung Biologics Corporate Information, Head Office, and Major Competitors

Table 15. Samsung Biologics Major Business

Table 16. Samsung Biologics CMO and CDMO biotechnology Product and Solutions

Table 17. Samsung Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Lonza. Corporate Information, Head Office, and Major Competitors

Table 19. Lonza. Major Business

Table 20. Lonza. CMO and CDMO biotechnology Product and Solutions

Table 21. Lonza. CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 23. Boehringer Ingelheim Major Business

Table 24. Boehringer Ingelheim CMO and CDMO biotechnology Product and Solutions

Table 25. Boehringer Ingelheim CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Samsung BioLogics Corporate Information, Head Office, and Major Competitors

Table 27. Samsung BioLogics Major Business

Table 28. Samsung BioLogics CMO and CDMO biotechnology Product and Solutions

Table 29. Samsung BioLogics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. AGC Biologics Corporate Information, Head Office, and Major Competitors

Table 31. AGC Biologics Major Business

Table 32. AGC Biologics CMO and CDMO biotechnology Product and Solutions

Table 33. AGC Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. WuXi Biologics Corporate Information, Head Office, and Major Competitors

Table 35. WuXi Biologics Major Business

Table 36. WuXi Biologics CMO and CDMO biotechnology Product and Solutions

Table 37. WuXi Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. AbbVie Corporate Information, Head Office, and Major Competitors

Table 39. AbbVie Major Business

Table 40. AbbVie CMO and CDMO biotechnology Product and Solutions

Table 41. AbbVie CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Avid Bioservices Corporate Information, Head Office, and Major Competitors

Table 43. Avid Bioservices Major Business

Table 44. Avid Bioservices CMO and CDMO biotechnology Product and Solutions

Table 45. Avid Bioservices CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Fujifilm Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors

Table 47. Fujifilm Diosynth Biotechnologies Major Business

Table 48. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product and Solutions

Table 49. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. KBI Biopharma (JSR Corporation) Corporate Information, Head Office, and Major Competitors

Table 51. KBI Biopharma (JSR Corporation) Major Business

Table 52. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product and Solutions

Table 53. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Cytovance Biologics Corporate Information, Head Office, and Major Competitors

Table 55. Cytovance Biologics Major Business

Table 56. Cytovance Biologics CMO and CDMO biotechnology Product and Solutions

Table 57. Cytovance Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Xpress Biologic Corporate Information, Head Office, and Major Competitors

Table 59. Xpress Biologic Major Business

Table 60. Xpress Biologic CMO and CDMO biotechnology Product and Solutions

Table 61. Xpress Biologic CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Rentschler Biopharma Corporate Information, Head Office, and Major Competitors

Table 63. Rentschler Biopharma Major Business

Table 64. Rentschler Biopharma CMO and CDMO biotechnology Product and Solutions

Table 65. Rentschler Biopharma CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global CMO and CDMO biotechnology Revenue (USD Million) by Players (2019-2021)

Table 67. Global CMO and CDMO biotechnology Revenue Share by Players (2019-2021)

Table 68. Breakdown of CMO and CDMO biotechnology by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. CMO and CDMO biotechnology Players Head Office, Products and Services Provided

Table 70. CMO and CDMO biotechnology Mergers & Acquisitions in the Past Five Years

Table 71. CMO and CDMO biotechnology New Entrants and Expansion Plans

Table 72. Global CMO and CDMO biotechnology Revenue (USD Million) by Type (2016-2021)

Table 73. Global CMO and CDMO biotechnology Revenue Share by Type (2016-2021)

Table 74. Global CMO and CDMO biotechnology Revenue Forecast by Type (2021-2026)

Table 75. Global CMO and CDMO biotechnology Revenue by Application (2016-2021)

Table 76. Global CMO and CDMO biotechnology Revenue Forecast by Application (2021-2026)

Table 77. North America CMO and CDMO biotechnology Revenue by Type (2016-2021) & (USD Million)

Table 78. North America CMO and CDMO biotechnology Revenue by Type (2021-2026) & (USD Million)

Table 79. North America CMO and CDMO biotechnology Revenue by Application (2016-2021) & (USD Million)

Table 80. North America CMO and CDMO biotechnology Revenue by Application (2021-2026) & (USD Million)

Table 81. North America CMO and CDMO biotechnology Revenue by Country (2016-2021) & (USD Million)

Table 82. North America CMO and CDMO biotechnology Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe CMO and CDMO biotechnology Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe CMO and CDMO biotechnology Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe CMO and CDMO biotechnology Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe CMO and CDMO biotechnology Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe CMO and CDMO biotechnology Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe CMO and CDMO biotechnology Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific CMO and CDMO biotechnology Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific CMO and CDMO biotechnology Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific CMO and CDMO biotechnology Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific CMO and CDMO biotechnology Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific CMO and CDMO biotechnology Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific CMO and CDMO biotechnology Revenue by Region (2021-2026) & (USD Million)

Table 95. South America CMO and CDMO biotechnology Revenue by Type (2016-2021) & (USD Million)

Table 96. South America CMO and CDMO biotechnology Revenue by Type (2021-2026) & (USD Million)

Table 97. South America CMO and CDMO biotechnology Revenue by Application (2016-2021) & (USD Million)

Table 98. South America CMO and CDMO biotechnology Revenue by Application (2021-2026) & (USD Million)

Table 99. South America CMO and CDMO biotechnology Revenue by Country (2016-2021) & (USD Million)

Table 100. South America CMO and CDMO biotechnology Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa CMO and CDMO biotechnology Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa CMO and CDMO biotechnology Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa CMO and CDMO biotechnology Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa CMO and CDMO biotechnology Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa CMO and CDMO biotechnology Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa CMO and CDMO biotechnology Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. CMO and CDMO biotechnology Picture

Figure 2. Global CMO and CDMO biotechnology Revenue Market Share by Type in 2020

Figure 3. Service

Figure 4. Product

Figure 5. Platform/ Expression System

Figure 6. CMO and CDMO biotechnology Revenue Market Share by Application in 2020

Figure 7. Large Enterprise Picture

Figure 8. SME Picture

Figure 9. Global CMO and CDMO biotechnology Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global CMO and CDMO biotechnology Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global CMO and CDMO biotechnology Revenue Market Share by Region (2016-2026)

Figure 12. Global CMO and CDMO biotechnology Revenue Market Share by Region in 2020

Figure 13. North America CMO and CDMO biotechnology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe CMO and CDMO biotechnology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific CMO and CDMO biotechnology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America CMO and CDMO biotechnology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa CMO and CDMO biotechnology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. CMO and CDMO biotechnology Market Drivers

Figure 19. CMO and CDMO biotechnology Market Restraints

Figure 20. CMO and CDMO biotechnology Market Trends

Figure 21. Patheon Recent Developments and Future Plans

Figure 22. Catalent Recent Developments and Future Plans

Figure 23. Samsung Biologics Recent Developments and Future Plans

Figure 24. Lonza. Recent Developments and Future Plans

Figure 25. Boehringer Ingelheim Recent Developments and Future Plans

Figure 26. Samsung BioLogics Recent Developments and Future Plans

Figure 27. AGC Biologics Recent Developments and Future Plans

Figure 28. WuXi Biologics Recent Developments and Future Plans

Figure 29. AbbVie Recent Developments and Future Plans

Figure 30. Avid Bioservices Recent Developments and Future Plans

Figure 31. Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans

Figure 32. KBI Biopharma (JSR Corporation) Recent Developments and Future Plans

Figure 33. Cytovance Biologics Recent Developments and Future Plans

Figure 34. Xpress Biologic Recent Developments and Future Plans

Figure 35. Rentschler Biopharma Recent Developments and Future Plans

Figure 36. Global CMO and CDMO biotechnology Revenue Share by Players in 2020

Figure 37. CMO and CDMO biotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players CMO and CDMO biotechnology Revenue Market Share in 2020

Figure 39. Global Top 10 Players CMO and CDMO biotechnology Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global CMO and CDMO biotechnology Revenue Share by Type in 2020

Figure 42. Global CMO and CDMO biotechnology Market Share Forecast by Type (2021-2026)

Figure 43. Global CMO and CDMO biotechnology Revenue Share by Application in 2020

Figure 44. Global CMO and CDMO biotechnology Market Share Forecast by Application (2021-2026)

Figure 45. North America CMO and CDMO biotechnology Sales Market Share by Type (2016-2026)

Figure 46. North America CMO and CDMO biotechnology Sales Market Share by Application (2016-2026)

Figure 47. North America CMO and CDMO biotechnology Revenue Market Share by Country (2016-2026)

Figure 48. United States CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe CMO and CDMO biotechnology Sales Market Share by Type (2016-2026)

Figure 52. Europe CMO and CDMO biotechnology Sales Market Share by Application (2016-2026)

Figure 53. Europe CMO and CDMO biotechnology Revenue Market Share by Country (2016-2026)

Figure 54. Germany CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific CMO and CDMO biotechnology Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific CMO and CDMO biotechnology Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific CMO and CDMO biotechnology Revenue Market Share by Region (2016-2026)

Figure 62. China CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America CMO and CDMO biotechnology Sales Market Share by Type (2016-2026)

Figure 69. South America CMO and CDMO biotechnology Sales Market Share by Application (2016-2026)

Figure 70. South America CMO and CDMO biotechnology Revenue Market Share by Country (2016-2026)

Figure 71. Brazil CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa CMO and CDMO biotechnology Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa CMO and CDMO biotechnology Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa CMO and CDMO biotechnology Revenue Market Share by Country (2016-2026)

Figure 76. Turkey CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE CMO and CDMO biotechnology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source